These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15251162)

  • 1. Quality assurance of the EORTC 26981/22981; NCIC CE3 intergroup trial on radiotherapy with or without temozolomide for newly-diagnosed glioblastoma multiforme: the individual case review.
    Ataman F; Poortmans P; Stupp R; Fisher B; Mirimanoff RO
    Eur J Cancer; 2004 Jul; 40(11):1724-30. PubMed ID: 15251162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide.
    Minniti G; Amelio D; Amichetti M; Salvati M; Muni R; Bozzao A; Lanzetta G; Scarpino S; Arcella A; Enrici RM
    Radiother Oncol; 2010 Dec; 97(3):377-81. PubMed ID: 20855119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.
    Gorlia T; van den Bent MJ; Hegi ME; Mirimanoff RO; Weller M; Cairncross JG; Eisenhauer E; Belanger K; Brandes AA; Allgeier A; Lacombe D; Stupp R
    Lancet Oncol; 2008 Jan; 9(1):29-38. PubMed ID: 18082451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.
    Mirimanoff RO; Gorlia T; Mason W; Van den Bent MJ; Kortmann RD; Fisher B; Reni M; Brandes AA; Curschmann J; Villa S; Cairncross G; Allgeier A; Lacombe D; Stupp R
    J Clin Oncol; 2006 Jun; 24(16):2563-9. PubMed ID: 16735709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commentary on Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial (Lancet Oncol. 2009;10:459-466).
    Linz U
    Cancer; 2010 Apr; 116(8):1844-6. PubMed ID: 20151424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
    Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
    Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant (without adjuvant) temozolomide and radiation to treat glioblastoma: a retrospective study.
    Sridhar T; Gore A; Boiangiu I; Machin D; Symonds RP
    Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):19-22. PubMed ID: 18838255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolution of chemoradiation for glioblastoma: a modern success story.
    Mirimanoff RO
    Curr Oncol Rep; 2006 Jan; 8(1):50-3. PubMed ID: 16464403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Going past the data for temozolomide.
    Villano JL; Letarte N; Bressler LR
    Cancer Chemother Pharmacol; 2012 Apr; 69(4):1113-5. PubMed ID: 22147076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme.
    Athanassiou H; Synodinou M; Maragoudakis E; Paraskevaidis M; Verigos C; Misailidou D; Antonadou D; Saris G; Beroukas K; Karageorgis P
    J Clin Oncol; 2005 Apr; 23(10):2372-7. PubMed ID: 15800329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy quality assurance for the RTOG 0834/EORTC 26053-22054/NCIC CTG CEC.1/CATNON intergroup trial "concurrent and adjuvant temozolomide chemotherapy in newly diagnosed non-1p/19q deleted anaplastic glioma": Individual case review analysis.
    Abrunhosa-Branquinho AN; Bar-Deroma R; Collette S; Clementel E; Liu Y; Hurkmans CW; Feuvret L; Van Beek K; van den Bent M; Baumert BG; Weber DC
    Radiother Oncol; 2018 May; 127(2):292-298. PubMed ID: 29606522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality assurance in the EORTC 22033-26033/CE5 phase III randomized trial for low grade glioma: the digital individual case review.
    Fairchild A; Weber DC; Bar-Deroma R; Gulyban A; Fenton PA; Stupp R; Baumert BG
    Radiother Oncol; 2012 Jun; 103(3):287-92. PubMed ID: 22560713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy for malignant gliomas.
    Marosi C
    Wien Med Wochenschr; 2006 Jun; 156(11-12):346-50. PubMed ID: 16944366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme: a report from the EORTC 26981/22981 NCI-C CE3 Intergroup Study.
    Lamers LM; Stupp R; van den Bent MJ; Al MJ; Gorlia T; Wasserfallen JB; Mittmann N; Jin Seung S; Crott R; Uyl-de Groot CA;
    Cancer; 2008 Mar; 112(6):1337-44. PubMed ID: 18213621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of the EORTC/NCIC Trial Protocol in a Neurosurgical Outpatient Unit: The Case for Neurosurgical Neuro-Oncology.
    Rapp M; Sadat H; Slotty PJ; Steiger HJ; Budach W; Sabel M
    J Neurol Surg A Cent Eur Neurosurg; 2015 Jul; 76(4):298-302. PubMed ID: 25915500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life in patients with glioblastoma: a randomised controlled trial.
    Taphoorn MJ; Stupp R; Coens C; Osoba D; Kortmann R; van den Bent MJ; Mason W; Mirimanoff RO; Baumert BG; Eisenhauer E; Forsyth P; Bottomley A; ; ;
    Lancet Oncol; 2005 Dec; 6(12):937-44. PubMed ID: 16321761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current developments in the radiotherapy approach to elderly and frail patients with glioblastoma multiforme.
    Roa W; Xing JZ; Small C; Kortmann R; Miriamanoff R; Okunieff P; Shibamoto Y; Jeremic B
    Expert Rev Anticancer Ther; 2009 Nov; 9(11):1643-50. PubMed ID: 19895247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I dose escalation study using simultaneous integrated-boost IMRT with temozolomide in patients with unifocal glioblastoma.
    Truc G; Bernier V; Mirjolet C; Dalban C; Mazoyer F; Bonnetain F; Blanchard N; Lagneau É; Maingon P; Noël G
    Cancer Radiother; 2016 May; 20(3):193-8. PubMed ID: 27117900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sequential use of carmustine wafers (Gliadel®) and post-operative radiotherapy with concomitant temozolomide followed by adjuvant temozolomide: a clinical review.
    Dixit S; Hingorani M; Achawal S; Scott I
    Br J Neurosurg; 2011 Aug; 25(4):459-69. PubMed ID: 21344976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in translational research provide a rationale for clinical re-evaluation of high-dose radiotherapy for glioblastoma.
    Nieder C; Mehta MP
    Med Hypotheses; 2011 Mar; 76(3):410-3. PubMed ID: 21112157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.